'The Top Line': Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies

In this episode of "The Top Line," Annalee Armstrong and Gabrielle Masson shine a spotlight on some of the most promising companies in the biotech world.

Additionally, you'll have the opportunity to hear from Kevin Dunleavy as he engages in a conversation with Ray Pressburger from Accenture, discussing drug commercialization and the models that are proving to be the most effective.


To learn more about the topics in this episode: 


To Listen to More Episodes from The Top Line